HALO Overview

Company Profile

Related stocks

BBIO • United States

BridgeBio Pharma, Inc.

65.35 USD

12.78B USD 1Y +17.6%

AXSM • United States

Axsome Therapeutics, Inc.

168.35 USD

8.82B USD 1Y +43.3%

CAI • United States

Caris Life Sciences, Inc.

29.7 USD

8.39B USD 1Y -16.5%

INSM • United States

Insmed Incorporated

100.6 USD

21.97B USD 1Y -37.9%

NUVL • United States

Nuvalent, Inc.

123.96 USD

9.79B USD

PCVX • United States

Vaxcyte, Inc.

71.38 USD

10.62B USD 1Y +59.6%

TECH • United States

Bio-Techne Corp

72.46 USD

11.36B USD 1Y +19.6%

IMVT • United States

Immunovant, Inc.

30.47 USD

6.29B USD 1Y +88.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Region

Sector

Industry

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

40.4% p.a.

Max Drawdown (5Y)

-49.1%

Sharpe Ratio (5Y)

0.53

Beta Factor

0.88

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 1518%.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -49.1% in the extended horizon.